{"id":"https://openalex.org/W7225456979","doi":"https://doi.org/10.1007/s41030-026-00400-y","title":"Contemporary Inhaled Maintenance Therapy Patterns and Treatment Progression for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Findings from the DUALITY Patient Journey Study","display_name":"Contemporary Inhaled Maintenance Therapy Patterns and Treatment Progression for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Findings from the DUALITY Patient Journey Study","publication_year":2026,"publication_date":"2026-11-07","ids":{"openalex":"https://openalex.org/W7225456979","doi":"https://doi.org/10.1007/s41030-026-00400-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/42998215"},"language":"en","primary_location":{"id":"doi:10.1007/s41030-026-00400-y","doi":"https://doi.org/10.1007/s41030-026-00400-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s41030-026-00400-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s41030-026-00400-y.pdf","source":{"id":"https://openalex.org/S4210196224","display_name":"Pulmonary Therapy","issn_l":"2364-1746","issn":["2364-1746","2364-1754"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s41030-026-00400-y.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077961580","display_name":"Trishul Siddharthan","orcid":"https://orcid.org/0000-0001-9914-1839","observed_orcids":["https://orcid.org/0000-0001-9914-1839"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Trishul Siddharthan","raw_affiliation_strings":["Miller School of Medicine, University of Miami, 1600 NW 10th Avenue, Suite 1149, Miami, FL, 33136, USA. tsiddhar@miami.edu"],"raw_orcid":"https://orcid.org/0000-0001-9914-1839","affiliations":[{"raw_affiliation_string":"Miller School of Medicine, University of Miami, 1600 NW 10th Avenue, Suite 1149, Miami, FL, 33136, USA. tsiddhar@miami.edu","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041730805","display_name":"Hayley Drew Germack","orcid":"https://orcid.org/0000-0002-0035-6301","observed_orcids":["https://orcid.org/0000-0002-0035-6301"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hayley D. Germack","raw_affiliation_strings":["US Medical Evidence, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Medical Evidence, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069181451","display_name":"Jessica K. DeMartino","orcid":"https://orcid.org/0000-0002-4685-3450","observed_orcids":["https://orcid.org/0000-0002-4685-3450"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica K. DeMartino","raw_affiliation_strings":["US Medical Evidence, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Medical Evidence, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065858299","display_name":"Donna D. Carstens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donna D. Carstens","raw_affiliation_strings":["US Medical-Respiratory, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Medical-Respiratory, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161228120","display_name":"Peter S. Baudy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter S. Baudy","raw_affiliation_strings":["US Medical-Respiratory, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Medical-Respiratory, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049077816","display_name":"Martina C. Holder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martina C. Holder","raw_affiliation_strings":["US Medical-Respiratory, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Medical-Respiratory, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161233346","display_name":"Lisa Willshaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Willshaw","raw_affiliation_strings":["US Payer Medical, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Payer Medical, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117508267","display_name":"AMANDA K SPY","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Spy","raw_affiliation_strings":["US Medical-Respiratory, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Medical-Respiratory, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035382308","display_name":"Ambika Satija","orcid":"https://orcid.org/0000-0001-9874-0522","observed_orcids":["https://orcid.org/0000-0001-9874-0522"]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ambika Satija","raw_affiliation_strings":["Analysis Group, 111 Huntington Avenue, 14th Floor, Boston, MA, 02199, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, 111 Huntington Avenue, 14th Floor, Boston, MA, 02199, USA","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161228370","display_name":"Jessica Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Smith","raw_affiliation_strings":["Analysis Group, 111 Huntington Avenue, 14th Floor, Boston, MA, 02199, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, 111 Huntington Avenue, 14th Floor, Boston, MA, 02199, USA","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111352212","display_name":"Fengyi Jiang","orcid":"https://orcid.org/0009-0007-9420-5259","observed_orcids":["https://orcid.org/0009-0007-9420-5259"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fengyi Jiang","raw_affiliation_strings":["Analysis Group, First Canadian Place, 100 King Street West, Suite 4410, Toronto, ON, M5X 1A9, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, First Canadian Place, 100 King Street West, Suite 4410, Toronto, ON, M5X 1A9, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106399861","display_name":"Holly Arscott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Holly Arscott","raw_affiliation_strings":["Analysis Group, Tour Deloitte, 1190 Avenue des Canadiens-de-Montr\u00e9al, Suite 1500, Montreal, QC, H3B 0G7, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Tour Deloitte, 1190 Avenue des Canadiens-de-Montr\u00e9al, Suite 1500, Montreal, QC, H3B 0G7, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053962996","display_name":"Marjolaine Gauthier\u2010Loiselle","orcid":"https://orcid.org/0000-0002-9439-595X","observed_orcids":["https://orcid.org/0000-0002-9439-595X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marjolaine Gauthier-Loiselle","raw_affiliation_strings":["Analysis Group, Tour Deloitte, 1190 Avenue des Canadiens-de-Montr\u00e9al, Suite 1500, Montreal, QC, H3B 0G7, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analysis Group, Tour Deloitte, 1190 Avenue des Canadiens-de-Montr\u00e9al, Suite 1500, Montreal, QC, H3B 0G7, Canada","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031202842","display_name":"Henry Naddaf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry Naddaf","raw_affiliation_strings":["The Toledo Clinic, 4235 Secor Rd, Bldg 1, Upper Level, Toledo, OH, 43623, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Toledo Clinic, 4235 Secor Rd, Bldg 1, Upper Level, Toledo, OH, 43623, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5077961580"],"corresponding_institution_ids":["https://openalex.org/I145608581"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.7749999761581421},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.8870000243186951},{"id":"https://openalex.org/keywords/long-acting-muscarinic-antagonist","display_name":"long-acting muscarinic antagonist","score":0.902999997138977},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.8659999966621399},{"id":"https://openalex.org/keywords/beta-adrenergic-agonists","display_name":"beta-adrenergic agonists","score":0.7649999856948853},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.9279999732971191},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.7799999713897705},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6740000247955322},{"id":"https://openalex.org/keywords/unmet-needs","display_name":"unmet needs","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9211999773979187},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.8497999906539917},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.8177000284194946},{"id":"https://openalex.org/C2992779976","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Pulmonary disease","level":2,"score":0.4869000017642975},{"id":"https://openalex.org/C2780911369","wikidata":"https://www.wikidata.org/wiki/Q753853","display_name":"Lama","level":3,"score":0.44850000739097595},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4205999970436096},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.41440001130104065},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3564000129699707},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.34929999709129333},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.336899995803833},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3296999931335449},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.3109000027179718},{"id":"https://openalex.org/C2992556508","wikidata":"https://www.wikidata.org/wiki/Q12147","display_name":"Health maintenance","level":3,"score":0.3034999966621399},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.29019999504089355},{"id":"https://openalex.org/C2991922776","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Inhaled corticosteroids","level":3,"score":0.27970001101493835},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.2614000141620636},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.25940001010894775},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.2574999928474426},{"id":"https://openalex.org/C2777104659","wikidata":"https://www.wikidata.org/wiki/Q3508797","display_name":"Obstructive lung disease","level":3,"score":0.25679999589920044}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1007/s41030-026-00400-y","doi":"https://doi.org/10.1007/s41030-026-00400-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s41030-026-00400-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s41030-026-00400-y.pdf","source":{"id":"https://openalex.org/S4210196224","display_name":"Pulmonary Therapy","issn_l":"2364-1746","issn":["2364-1746","2364-1754"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Therapy","raw_type":"journal-article"},{"id":"pmid:42998215","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42998215","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s41030-026-00400-y","doi":"https://doi.org/10.1007/s41030-026-00400-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s41030-026-00400-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s41030-026-00400-y.pdf","source":{"id":"https://openalex.org/S4210196224","display_name":"Pulmonary Therapy","issn_l":"2364-1746","issn":["2364-1746","2364-1754"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","oarl","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225456979.pdf","grobid_xml":"https://content.openalex.org/works/W7225456979.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W2066616351","https://openalex.org/W2105673189","https://openalex.org/W2121656227","https://openalex.org/W2131237771","https://openalex.org/W2277233248","https://openalex.org/W2613136430","https://openalex.org/W2939604500","https://openalex.org/W2944297150","https://openalex.org/W3047163368","https://openalex.org/W3093211622","https://openalex.org/W3153227158","https://openalex.org/W3156431662","https://openalex.org/W3168416251","https://openalex.org/W4226115219","https://openalex.org/W4306386122","https://openalex.org/W4384820161","https://openalex.org/W4385226770","https://openalex.org/W4395448014","https://openalex.org/W4401664331","https://openalex.org/W4411103804","https://openalex.org/W4411182679"],"related_works":["https://openalex.org/W7161545660","https://openalex.org/W4404046679","https://openalex.org/W7161547482","https://openalex.org/W4214886415","https://openalex.org/W3166146085","https://openalex.org/W4323074328","https://openalex.org/W4205199942","https://openalex.org/W2898568303","https://openalex.org/W2008074564","https://openalex.org/W4294221650"],"abstract_inverted_index":{"INTRODUCTION:":[0],"-agonists":[1],"[LABA],":[2],"long-acting":[3],"muscarinic":[4],"antagonists":[5],"[LAMA],":[6],"and":[7,94,122,161,165,199,267,287,289],"inhaled":[8,112,176,210,239,296],"corticosteroids":[9],"[ICS],":[10],"used":[11],"alone":[12],"or":[13,72,134,171],"in":[14,34],"combination)":[15],"is":[16,276],"the":[17,35,73,182,231],"cornerstone":[18],"of":[19,109,125,144,159,167,238,248],"chronic":[20],"obstructive":[21],"pulmonary":[22],"disease":[23],"(COPD)":[24],"management.":[25],"This":[26],"study":[27],"described":[28,118],"contemporary":[29],"real-world":[30,224],"COPD":[31,47,67,76,148,232],"treatment":[32,185,283],"patterns":[33,116],"USA.":[36],"METHODS:":[37],"Retrospective":[38],"data":[39],"for":[40,62,78,87,111,260],"patients":[41,63,129,146,168,291],"aged":[42],"\u2265":[43,88,95,131,135],"40":[44],"years":[45],"with":[46,64,147,169,245,257,292],"were":[48,117,149,253],"obtained":[49],"from":[50],"Komodo":[51],"Research":[52],"Data":[53],"(01/01/2016-06/30/2024).":[54],"The":[55],"index":[56],"date":[57],"was":[58,85,181,227,272],"January":[59],"1,":[60],"2022":[61],"a":[65,156,246],"prior":[66],"diagnosis":[68,77],"(i.e.,":[69,92,102,130],"prevalent":[70,153,172],"patients)":[71],"first":[74],"observed":[75],"incident":[79,170],"patients.":[80],"Continuous":[81],"health":[82],"insurance":[83],"enrollment":[84],"required":[86],"12":[89],"months":[90,97],"pre-index":[91],"baseline)":[93],"6":[96],"post-index,":[98],"unless":[99],"death":[100],"occurred":[101],"follow-up).":[103],"A":[104,142],"claims-based":[105],"algorithm":[106],"identified":[107,150],"lines":[108],"therapy":[110,180,196,212,214,217,251,271],"maintenance":[113,177,211,240,297],"treatments.":[114],"Treatment":[115],"during":[119,139],"follow-up,":[120],"overall":[121],"among":[123,243],"subgroups":[124],"interest,":[126],"including":[127,242],"at-risk":[128,204],"1":[132],"severe":[133],"2":[136],"moderate":[137],"exacerbations":[138],"baseline).":[140],"RESULTS:":[141],"total":[143],"1,421,278":[145],"(incident":[151],"153,390;":[152],"1,267,888).":[154],"Over":[155],"mean":[157],"follow-up":[158],"16.6":[160],"24.7":[162],"months,":[163],"33.0%":[164],"51.2%":[166],"COPD,":[173],"respectively,":[174],"received":[175,208],"therapy.":[178,298],"Dual":[179],"most":[183],"common":[184],"class":[186],"(20.2%,":[187],"32.5%),":[188],"driven":[189],"by":[190,194,235],"ICS/LABA":[191],"use,":[192],"followed":[193],"triple":[195,216,270],"(12.5%,":[197],"22.5%),":[198],"monotherapy":[200,219],"(7.6%,":[201],"12.0%).":[202],"Among":[203],"patients,":[205],"only":[206],"58.8%":[207],"any":[209],"(dual":[213],"37.0%,":[215],"27.8%,":[218],"13.2%).":[220],"CONCLUSIONS:":[221],"In":[222],"this":[223],"study,":[225],"there":[226],"unmet":[228,293],"need":[229,294],"across":[230],"journey,":[233],"evidenced":[234],"low":[236],"uptake":[237],"therapy,":[241],"those":[244],"history":[247],"exacerbations.":[249],"Maintenance":[250],"regimens":[252],"not":[254],"fully":[255],"aligned":[256],"Global":[258],"Initiative":[259],"Chronic":[261],"Obstructive":[262],"Lung":[263],"Diseases":[264],"recommended":[265],"treatment,":[266],"persistence":[268],"to":[269,278,281],"limited.":[273],"Further":[274],"research":[275],"warranted":[277],"understand":[279],"barriers":[280],"timely":[282],"initiation,":[284],"optimize":[285],"escalation":[286],"persistence,":[288],"identify":[290],"despite":[295]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-08T00:00:00"}